EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches

Benson M Hamooya, Lukundo Siame, Lweendo Muchaili, Sepiso K Masenga, Annet Kirabo

Frontiers in Nutrition · 03.09.2025 · 12

DOI: 10.3389/fnut.2025.1661603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 03.09.2025. Verfasst von Benson M Hamooya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 377 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome (MetS) is a complex condition marked by central obesity, dyslipidemia, hypertension, insulin resistance, oxidative stress, and chronic inflammation. These risk factors significantly raise the risk of cardiovascular disease (CVD) through various mechanisms, leading to a public health challenge. MetS contributes to CVD through cardiometabolic derangements such as endothelial dysfunction, atherosclerosis, oxidative stress, and inflammation. Dyslipidemia, especially elevated triglycerides and reduced high-density lipo-protein (HDL) cholesterol is central to atherosclerosis. Additionally, hypertension and insulin resistance damage blood vessels, a process exacerbated by chronic inflammation and oxidative stress. Thus, managing MetS and its components through lifestyle changes like weight control, dietary improvements, exercise, and smoking cessation is essential for reducing CVD risk. Medications targeting specific risk factors, such as blood sugar, cholesterol, and blood pressure, may also be required. Raising awareness and early screening are crucial to countering MetS’s impact on public health. This review provides a comprehensive overview of the mechanisms by which MetS contributes to CVD and the intricate interplay of factors and molecular pathways linking MetS to CVD.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseasedyslipidemiahypertensioninflammationinsulin resistancemetabolic syndromeobesityoxidative stress

Autor:innen und Institutionen

  • Department of Public Health, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
  • Department of Cardiovascular Science and Metabolic Diseases, Livingstone Center for Prevention and Translational Science, Livingstone, Zambia.
  • Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN, United States.

Förderung

  • National Institutes of Health

Zitieren

APA

Hamooya, B. M., Siame, L., Muchaili, L., Masenga, S. K., & Kirabo, A. (2025). Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1661603

Vancouver

Hamooya BM, Siame L, Muchaili L, Masenga SK, Kirabo A. Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1661603

BibTeX
@article{Hamooya2025,
  author = {Hamooya, Benson M and Siame, Lukundo and Muchaili, Lweendo and Masenga, Sepiso K and Kirabo, Annet},
  title = {Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches},
  journal = {Frontiers in Nutrition},
  year = {2025},
  volume = {12},
  doi = {10.3389/fnut.2025.1661603}
}
Kostenlos starten →